Once a drug target is identified, it often takes decades until a chemical compound is developed that can hit the bullseye and ...

PolyActiva and RareSight collaborate to create innovative therapies for rare pediatric retinal diseases, aiming to transform ...

One such question, asked every now and then, is why humans float more easily in saltwater. There are a few places in the world where this is especially apparent, for example in the Dead Sea, or in the ...

Ultraviolet light causes damage to DNA, leads to cancer and photoaging: age spots and wrinkles. I was curious about this ...

A new technical paper titled “The van der Waals Gap: a Hidden Showstopper in Semiconductor Device Scaling” was published by ...

Learn how moving beyond ELISA can streamline your cell line development and boost productivity without compromising results.

This dual cross-linking design lets the muscle switch stiffness on demand. In lab tests, its stiffness jumps from about 213 ...

PolyActiva, a clinical-stage biopharmaceutical company pioneering a novel drug delivery technology to improve outcomes for patients with ocular conditions, and RareSight, Inc., an ...

Scientists at the University of Birmingham have developed a new class of MRI contrast agents, improving their stability to ...

DelveInsight's Chronic Progressive Multiple Sclerosis Market Insights report includes a comprehensive understanding of current treatment practices, chronic progressive multiple sclerosis emerging ...